Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3021691	b-plas-p	— (—)	55	126	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Fever of other and unknown origin

23.48

20.00

2.5

2.3

—

Intestinal infectious diseases

7.05

15.44

2.2

2.4

—

Diarrhoea and gastroenteritis of presumed infectious origin

6.75

7.49

2.1

2.5

—

General symptoms and signs

5.01

6.94

2.5

2.3

—

Intestinal infectious diseases

4.23

6.51

2.1

2.4

—

Persons with potential health hazards related to communicable diseases

7.44

5.58

2.3

2.4

—

Contact with and exposure to communicable diseases

7.83

5.32

2.2

2.4

—

Explicit Sepsis

6.42

4.68

3.0

2.3

—

Other septicaemia

8.66

4.65

3.3

2.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.66

4.37

1.8

2.4

—

Certain infectious and parasitic diseases

4.12

4.24

2.7

1.9

—

Second line medication for Crohn's disease

4.80

4.17

2.0

2.5

—

L04AX Other immunosuppressants

4.80

4.17

2.0

2.5

—

Septicaemia

7.02

4.14

3.3

2.1

—

ILD medications: immunosuppressive drugs

4.31

4.06

2.4

2.5

—

Other bacterial diseases

3.48

3.85

2.8

2.1

—

Bronchitis

3.06

3.80

1.9

2.5

—

Inflammatory bowel disease, strict (require KELA)

7.78

3.55

2.3

2.9

—

IBD patients in KELA-register

7.78

3.55

2.3

2.9

—

Exposure to unspecified factor

2.95

3.53

2.2

2.3

—

Renal tubulo-interstitial diseases

3.23

3.33

2.8

2.1

—

COPD/asthma/ILD related infections

3.34

3.30

2.3

2.0

—

COPD/asthma related infections

3.34

3.30

2.3

2.0

—

Influenza and pneumonia

2.83

3.19

2.8

2.0

—

Inflammatory bowel disease

6.37

3.18

2.3

2.8

—

Other/unspecified dorsalgia

4.67

2.89

2.5

2.8

—

All influenza

6.67

2.86

2.0

—

Persons encountering health services in other circumstances

3.89

2.75

1.9

2.5

—

ILD medications: azathioprine

8.34

2.75

2.6

2.8

—

Azathioprine

8.34

2.75

2.6

2.8

—

Ectopic pregnancy

8.34

2.75

2.2

2.7

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

8.33

2.75

2.2

2.8

—

Acute upper respiratory infections of multiple and unspecified sites

3.07

2.65

1.9

2.4

—

2.78

2.58

2.1

2.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

7.15

2.55

2.4

2.7

—

Ulcerative colitis (strict definition, require KELA)

7.14

2.55

2.4

2.7

—

Covid-19 confirmed case

4.38

2.47

2.4

—

ILD medications

2.48

2.45

2.1

2.3

—

Other bacterial diseases

2.66

2.37

2.9

2.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

6.25

2.37

2.4

2.6

—

Peritonsillar abscess

6.25

2.37

1.4

2.4

—

Dysphagia

6.25

2.37

1.6

2.0

—

5-aminosalicylic acid

6.25

2.37

2.4

2.8

—

Other diseases of urinary system

2.61

2.22

1.8

2.5

—

Ulcerative colitis

5.56

2.21

2.4

2.7

—

Diseases of liver

4.29

2.15

2.7

2.4

—

Asthma-related pneumonia

4.28

2.14

2.8

2.1

—

Asthma, hospital admissions 3, pneumonia

4.28

2.14

2.8

2.1

—

Asthma-related pneumonia or sepsis

4.28

2.14

2.8

2.1

—

Cystitis

2.64

2.14

1.8

2.3

—

Acute upper respiratory infections

2.50

2.12

2.2

2.4

—

Acute tubulo-interstitial nephritis

2.99

2.09

2.8

2.3

—

Disorders of sclera, cornea, iris and ciliary body

3.20

2.09

2.0

2.6

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.88

2.08

3.0

2.0

—

2.88

2.08

3.0

2.0

—

Umbilical hernia

5.00

2.07

2.6

2.4

—

All pneumoniae

2.41

2.03

3.2

2.0

—

All kidney diseases

2.40

2.02

2.8

2.1

—

Sleep apnoea

2.64

2.00

2.0

2.3

—

Pneumonia, organism unspecified

2.57

1.96

2.7

2.0

—

Sleep apnoea, including avohilmo

2.48

1.94

2.4

2.5

—

Hernia of abdominal wall

3.75

1.93

2.5

2.3

—

Codes for special purposes

2.96

1.93

2.5

—

Provisional assignment of new diseases of uncertain etiology

2.96

1.93

2.5

—

Symptoms and signs involving the urinary system

2.74

1.88

2.7

2.3

—

Noninfective enteritis and colitis

3.18

1.87

2.3

2.5

—

Sleep disorders (combined)

2.30

1.87

2.1

2.3

—

Malaise and fatigue

4.47

1.85

2.6

—

Unspecified fall

3.14

1.84

2.0

2.5

—

Dorsalgia

2.27

1.84

2.3

2.4

—

Other disorders of urethra and urinary system

2.71

1.83

1.9

2.3

—

Autoimmune diseases related-to ILD

2.41

1.82

2.1

2.4

—

Codeine

2.41

1.79

1.9

2.2

—

Bacterial infection, other or unspecified

3.47

1.77

2.7

2.1

—

Asthma, hospital admission 2, infections

2.70

1.74

2.4

—

Asthma-related infections

2.70

1.74

2.4

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

3.85

1.71

1.6

2.6

—

Abnormalities of heart beat

3.77

1.68

2.4

2.5

—

Pneumonias (Asthma/COPD co-morbidities)

2.24

1.63

3.1

2.0

—

Bacterial infection, other or unspecified

3.17

1.63

2.7

2.2

—

Keratitis

3.57

1.61

1.8

2.5

—

In situ neoplasms

3.57

1.61

1.6

2.4

—

Urticaria

3.57

1.61

2.6

2.2

—

Implicit viral Sepsis

3.57

1.61

3.2

2.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

3.00

1.58

2.5

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.69

1.58

2.3

2.4

—

Diseases of the digestive system

2.99

1.57

2.3

2.5

—

STROKE

3.14

1.56

2.5

—

Codeine or tramadol medication

2.15

1.55

1.8

2.5

—

Inflammatory bowel disease treatment related agents

2.06

1.52

1.9

2.4

—

Venous thromboembolism

2.90

1.52

1.7

2.5

—

Ischemic heart diseases

2.57

1.52

1.6

2.5

—

Presence of other functional implants

2.97

1.49

1.5

1.8

—

Benzodiazepine use

2.12

1.46

2.3

—

Angina pectoris

3.33

1.44

2.2

2.3

—

Other arthritis (FG)

3.13

1.44

1.8

2.6

—

Gestational diabetes (for exclusion)

2.78

1.40

2.0

2.5

—

Oral corticosteroids

2.09

1.38

1.8

2.5

—

Examination and observation for other reasons

0.00

1.38

0.0

2.4

—

Bacterial Sepsis

3.05

1.38

3.0

2.2

—

Glucosamine medication

3.07

1.37

1.8

2.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.10

1.37

2.0

2.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.38

1.36

2.7

2.2

—

DVT of lower extremities and pulmonary embolism

2.93

1.35

1.6

2.2

—

First line medication for Crohn's disease

2.01

1.33

2.4

2.3

—

Opioids

2.08

1.32

2.1

2.2

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2.08

1.30

2.7

2.2

—

Other acute lower respiratory infections

2.49

1.29

1.8

2.7

—

Urticaria and erythema

2.78

1.28

2.6

2.3

—

Headache

2.52

1.28

1.3

2.3

—

Injuries to the wrist and hand

1.98

1.26

2.7

2.2

—

Injuries to the knee and lower leg

1.89

1.25

2.3

—

Coronary atherosclerosis

2.88

1.25

2.0

2.3

—

Visual disturbances and blindness

2.40

1.24

2.2

2.4

—

All chronic kidney diseases

2.73

1.23

2.6

2.7

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.60

1.20

3.2

2.5

—

Disorders of gallbladder, biliary tract and pancreas

2.10

1.19

1.6

2.6

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.30

1.18

2.8

2.1

—

Ischaemic heart disease, wide definition

2.41

1.14

2.6

2.1

—

Any mental disorder

1.94

1.12

2.9

2.3

—

Asthma (only as main-diagnosis), excluding more controls

2.35

1.12

2.3

2.2

—

Mental and behavioural disorders due to alcohol

2.40

1.09

2.6

2.5

—

Asthma (only as main-diagnosis)

2.25

1.08

2.3

—

Other viral diseases

2.36

1.08

2.2

2.3

—

Persons encountering health services in other circumstances, wide

1.81

1.03

1.8

2.5

—

Pain in throat and chest

1.93

1.02

2.3

2.4

—

Depression

1.86

1.00

2.0

2.4

—

Viral infections characterized by skin and mucous membrane lesions

1.90

1.00

2.2

2.3

—

Anxiety disorders, excluding more controls

1.89

1.00

2.6

2.3

—

Meniscus derangement

2.38

0.96

3.2

2.0

—

Tonsillectomy and adenotomy

1.95

0.95

2.3

—

Care involving use of rehabilitation procedures

0.00

0.95

0.0

2.3

—

Abdominal and pelvic pain

1.93

0.94

2.5

2.4

—

Obesity due to excess calories

2.22

0.93

2.2

2.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.86

0.92

2.8

2.3

—

Any gastric operation

2.01

0.92

3.0

2.2

—

GASTRO-related operations

2.01

0.92

3.0

2.2

—

Fall on same level involving ice and snow

2.14

0.91

3.3

2.3

—

Low back pain

1.91

0.89

2.5

—

Mental and behavioural disorders due to psychoactive substance use

2.06

0.88

2.7

2.4

—

Disease of hard tissues of teeth, NOS

2.09

0.88

2.5

2.2

—

Concussion

2.04

0.88

1.8

2.5

—

Episodal and paroxysmal disorders

1.74

0.86

1.9

2.4

—

Constipation

1.79

0.84

2.3

—

Other heart diseases, wide

1.80

0.82

1.8

2.5

—

Special screening examination for infectious and parasitic diseases

0.00

0.81

0.0

2.4

—

Certain infectious and parasitic diseases

2.28

0.78

3.2

1.9

—

Hernia

1.77

0.78

2.4

2.3

—

Benign neoplasm of colon, rectum, anus and anal canal

0.00

0.78

0.0

2.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.25

0.77

3.0

2.1

—

Mood disorders, excluding more controls

1.73

0.77

1.9

2.3

—

Excluding asthma or asthma-COPD overlap

1.95

0.76

3.1

2.3

—

Other pulmonary diagnosis

1.95

0.76

3.1

2.3

—

COPD differential diagnosis

1.95

0.76

3.1

2.3

—

ILD differential diagnosis

1.95

0.76

3.1

2.3

—

Spondylopathies

1.90

0.75

1.6

2.2

—

Substance abuse, excluding more controls

2.13

0.75

2.8

2.3

—

Polyarthropathies

1.90

0.75

2.7

2.3

—

Other functional intestinal disorders

2.11

0.75

2.6

2.5

—

Visual disturbances

2.08

0.74

2.0

2.4

—

Complications of medical and surgical care

1.84

0.73

2.7

2.2

—

Shoulder lesions

1.77

0.71

2.7

2.1

—

1.96

0.71

2.6

—

Transport accidents

1.95

0.71

1.6

2.4

—

Infections with a predominantly sexual mode of transmission

1.94

0.71

1.2

2.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.58

0.71

2.3

—

Disorders of lens

1.95

0.70

1.2

2.1

—

Injuries to the shoulder and upper arm

1.71

0.69

2.6

2.3

—

Hard cardiovascular diseases

1.67

0.68

1.4

2.6

—

Intracranial injury

1.82

0.67

1.6

2.9

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.81

0.67

2.0

2.1

—

Substance abuse

1.81

0.66

2.8

2.5

—

Injuries to the elbow and forearm

1.62

0.66

1.6

2.4

—

Disorders of skin appendages

1.78

0.66

1.2

2.4

—

1.76

0.65

2.6

2.5

—

Other and unspecified dermatitis

1.72

0.64

2.0

2.2

—

Osteopathies and chondropathies

1.72

0.63

3.0

2.4

—

Malignant neoplasm of breast, HER2-negative

0.00

0.62

0.0

1.9

—

Chronic periodontitis, including avohilmo

1.62

0.62

2.6

2.3

—

Periodontitis

1.62

0.62

2.6

2.3

—

Degeneration of macula and posterior pole

0.00

0.61

0.0

2.1

—

Malignant neoplasm of breast

0.00

0.61

0.0

1.9

—

Injuries to the head

1.57

0.60

1.5

2.5

—

Asthma, excluding more controls

1.84

0.60

2.0

2.2

—

Iron deficiency anaemia

0.00

0.60

0.0

2.3

—

Asthma (mode)

1.78

0.59

2.5

2.3

—

Psychiatric diseases

1.54

0.59

3.0

2.2

—

Metabolic disorders

1.52

0.59

1.6

2.6

—

Asthma

1.75

0.59

2.0

2.3

—

Benign neoplasm: Colon

0.00

0.58

0.0

2.2

—

Asthma, hospital admissions , main diagnosis only

1.50

0.58

2.4

2.3

—

Dislocation, sprain and strain of joints and ligaments of knee

1.73

0.58

2.2

2.3

—

Necrosis of pulp, including avohilmo

1.71

0.57

2.2

2.3

—

Intracranial trauma

1.69

0.57

1.8

2.6

—

Mood [affective] disorders

1.58

0.57

2.0

2.4

—

Mood disorders

1.58

0.57

2.0

2.4

—

Neurotic, stress-related and somatoform disorders

1.54

0.55

2.6

2.3

—

Anxiety disorders

1.53

0.55

2.6

2.3

—

Tramadol

1.60

0.55

3.0

2.1

—

Type 2 diabetes, wide definition

1.60

0.55

1.5

2.3

—

Insomnia

1.49

0.54

2.4

2.3

—

Depression or dysthymia

1.58

0.54

3.0

2.3

—

Symptoms and signs involving the skin and subcutaneous tissue

1.54

0.53

1.2

2.5

—

Disorders of lipoprotein metabolism and other lipidaemias

1.55

0.53

1.8

2.6

—

Obesity

1.52

0.52

2.2

2.3

—

Obesity and other hyperalimentation

1.52

0.52

2.2

2.3

—

Other nutritional deficiencies

1.49

0.51

2.2

2.3

—

Cardiovascular diseases

1.57

0.50

2.3

2.4

—

Lower back pain or/and sciatica

1.52

0.50

2.6

2.3

—

Complications of procedures, not elsewhere classified

1.52

0.48

2.7

2.3

—

Injuries to the ankle and foot

1.45

0.46

2.7

2.2

—

Dyspnoea

1.40

0.45

1.7

2.4

—

Abnormalities of breathing

1.45

0.43

1.6

2.3

—

Asthma (diagnoses ohter than nonallergic)

1.44

0.43

2.4

2.3

—

Asthma, including avohilmo

1.44

0.43

2.2

2.3

—

Leiomyoma of uterus

1.57

0.42

2.4

1.9

—

Diseases of the respiratory system

1.57

0.42

3.2

2.2

—

Falls/tendency to fall

1.47

0.42

2.5

2.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.42

0.0

2.2

—

Sulfonylureas

0.00

0.42

0.0

2.2

—

Fall on same level

1.43

0.42

2.2

2.3

—

Percutaneous Coronary Intervention

1.53

0.42

1.4

2.6

—

Coronary revascularization (ANGIO or CABG)

1.53

0.41

1.4

2.6

—

Bacterial pneumoniae

0.00

0.41

0.0

2.1

—

Complications of surgical and medical care, not elsewhere classified

1.37

0.41

2.6

2.3

—

Long labour

0.00

0.41

0.0

2.4

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

0.41

0.0

2.3

—

Other arrhythmias

1.51

0.41

1.2

2.3

—

Retinal detachments and breaks

0.00

0.41

0.0

2.1

—

Dental caries, including avohilmo

1.50

0.41

2.6

2.2

—

Dermatitis

1.51

0.41

2.0

2.4

—

Kela-code for severe mental illness

0.00

0.41

0.0

2.5

—

Other and unspecified iron deficiency

0.00

0.41

0.0

2.4

—

Diabetes, varying definitions

1.34

0.40

2.3

2.5

—

Sleep disorders

1.34

0.40

2.3

—

Bacterial pneumonia (organism specified)

0.00

0.40

0.0

2.2

—

Other dorsopathies, not elsewhere classified

1.43

0.40

1.8

2.4

—

Symptoms and signs involving the circulatory and respiratory systems

1.41

0.40

2.0

2.3

—

Dorsopathies

1.39

0.39

1.9

2.4

—

Gastro-oesophageal reflux disease

1.44

0.39

2.0

2.2

—

Diseases of the skin and subcutaneous tissue

1.37

0.39

1.7

2.5

—

Coxarthrosis, primary, with hip surgery

0.00

0.39

0.0

2.0

—

Implicit Sepsis

1.41

0.38

3.2

2.2

—

Excessive attrition of teeth

1.39

0.38

2.0

2.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.32

0.38

1.9

2.5

—

Dermatitis and eczema

1.41

0.36

1.9

2.4

—

Major coronary heart disease event

1.45

0.36

1.3

2.6

—

Cholelithiasis, broad definition with cholecystitis

1.44

0.36

1.8

2.4

—

All anxiety disorders

1.39

0.35

2.7

2.2

—

Statin medication

1.35

0.34

2.5

2.6

—

Artificial joint operation, meniscal resection

1.34

0.34

3.0

2.1

—

Other diseases of intestines

1.39

0.33

2.3

2.4

—

Exposure to other specified factors

1.31

0.33

3.3

2.1

—

Symptoms and signs involving the digestive system and abdomen

1.35

0.32

2.3

2.4

—

Pain in limb

1.38

0.32

3.0

2.1

—

Type 2 diabetes, definitions combined, including avohilmo

1.31

0.31

1.7

2.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.32

0.31

2.6

2.4

—

Diabetes mellitus

1.34

0.29

2.3

2.5

—

Other soft tissue disorders, not elsewhere classified

1.30

0.28

2.8

2.1

—

Other antidepressants

1.28

0.28

2.3

2.4

—

Diseases of oesophagus, stomach and duodenum

1.26

0.28

2.9

2.3

—

Asthma/COPD (KELA code 203)

1.22

0.27

1.6

2.3

—

Chronic apical periodontitis

1.28

0.26

2.4

—

Gonarthrosis [arthrosis of knee](FG)

1.32

0.23

3.2

1.8

—

Anxiety (asthma-related co-morbidities)

1.33

0.23

3.0

2.3

—

Cardiovascular diseases (excluding rheumatic etc)

1.31

0.23

2.4

2.5

—

Bleeding

1.32

0.23

2.6

2.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.31

0.23

3.2

2.1

—

Cholelithiasis

1.23

0.22

1.6

2.4

—

Caries of dentine, including avohilmo

1.22

0.22

2.8

2.1

—

Alzheimer disease, including avohilmo

0.00

0.22

0.0

2.1

—

Alzheimer disease

0.00

0.22

0.0

2.1

—

Hypertensive heart and/or renal disease

0.00

0.22

0.0

1.8

—

Hypertensive Heart Disease

0.00

0.22

0.0

1.8

—

Outcome of delivery

0.00

0.21

0.0

2.3

—

Crowding of teeth, including avohilmo

0.00

0.21

0.0

2.6

—

Perineal laceration during delivery

0.00

0.21

0.0

2.4

—

0.00

0.21

0.0

2.0

—

Gonarthrosis,primary

1.18

0.21

3.2

1.8

—

Non-invasive ventilation

0.00

0.21

0.0

2.6

—

Abnormal serum enzyme levels

0.00

0.21

0.0

2.5

—

Primary open-angle glaucoma, strict

0.00

0.21

0.0

1.9

—

Benign neoplasm: Colon, unspecified

0.00

0.21

0.0

1.6

—

Fibroblastic disorders

0.00

0.21

0.0

2.0

—

Speech therapy

0.00

0.21

0.0

1.5

—

Mycoses

0.00

0.21

0.0

1.6

—

Seropositive rheumatoid arthritis, wide

0.00

0.21

0.0

1.7

—

Cutaneous abscess, furuncle and carbuncle

0.00

0.21

0.0

2.8

—

Primary coxarthrosis, bilateral

0.00

0.21

0.0

1.8

—

Atopic dermatitis

1.17

0.21

1.8

2.3

—

Sequelae of cerebrovascular disease

0.00

0.21

0.0

2.1

—

Non-ischemic cardiomyopathy

0.00

0.21

0.0

2.1

—

Combinations of oral blood glucose lowering drugs

0.00

0.21

0.0

2.2

—

Symptoms and signs involving speech and voice

0.00

0.21

0.0

1.9

—

General examination and investigation of persons without complaint and reported diagnosis

1.25

0.21

2.2

2.4

—

Bacterial pneumonia, not elsewhere classified

0.00

0.20

0.0

2.1

—

Disorders of eyelid, lacrimal system and orbit

1.27

0.20

2.3

2.4

—

Dentofacial anomalies [including malocclusion]

1.27

0.20

2.0

2.3

—

Medical observation and evaluation for suspected diseases and conditions

1.23

0.20

3.3

2.4

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

0.20

0.0

2.4

—

Glucagon-like peptide-1 (GLP-1) analogues

0.00

0.20

0.0

2.4

—

Schizophrenia or delusion

0.00

0.20

0.0

2.5

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.20

0.0

2.5

—

Rheumatoid arthritis, including avohilmo

0.00

0.20

0.0

1.9

—

Candidiasis

0.00

0.20

0.0

2.3

—

Schizophrenia or delusion, excluding more controls

0.00

0.20

0.0

2.4

—

Rheumatoid arthritis

0.00

0.20

0.0

2.0

—

Hypothyroidism, strict autoimmune

1.16

0.19

1.8

2.3

—

Use of hypnotics and sedatives

1.22

0.18

2.3

2.5

—

Caries of enamel

0.75

0.17

3.8

2.1

—

External causes of morbidity and mortality

1.19

0.10

2.2

2.4

—

Emergency coronary revascularization (for ACS)

1.17

0.10

1.4

2.6

—

Malignant neoplasm, wide definition for exclusion

1.09

0.10

2.2

2.6

—

Accidents

1.04

0.09

2.0

2.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.04

0.09

3.2

2.1

—

Type 2 diabetes, strict (exclude DM1)

1.14

0.09

1.8

2.4

—

Type 2 diabetes, definitions combined

1.14

0.09

1.8

2.4

—

Other specific joint derangements/joint disorders

1.11

0.09

2.8

2.2

—

Chronic diseases of tonsils and adenoids

1.08

0.09

3.5

2.2

—

Polycystic ovarian syndrome, consortium definition

1.08

0.09

2.0

2.3

—

Type 2 diabetes

1.06

0.09

1.8

2.4

—

Triptan medication for migraine, single purchase ok

1.07

0.09

2.5

2.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.07

0.09

2.5

2.1

—

Neurological diseases

0.81

0.08

2.2

2.4

—

Diabetes, insulin treatment (Kela reimbursement)

0.82

0.08

1.8

2.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.83

0.08

2.0

2.4

—

Nerve, nerve root and plexus disorders

1.10

0.08

3.4

2.2

—

Disorders of the thyroid gland

1.06

0.08

1.7

2.3

—

Dental pulpitis, including avohilmo

1.06

0.08

2.3

—

Used for control exclusion in common control thyroid runs

0.82

0.08

2.3

2.2

—

Diseases of pulp and periapical tissues, including avohilmo

0.82

0.08

2.0

2.3

—

Diseases of the ear and mastoid process

0.82

0.07

1.9

2.3

—

Chronic lower respiratory diseases

1.06

0.07

2.0

2.3

—

severe traumatic brain injury, does not include concussion

0.00

0.0

1.8

—

Gastrointestinal diseases

1.00

0.00

2.6

2.5

—

Gingivitis and periodontal diseases

1.00

0.00

2.5

2.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.97

0.00

2.5

2.2

—

malignant neoplasm of male genital organs

0.00

0.0

3.0

—

Other specified and unspecified personality disorders

0.00

0.0

3.2

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.0

1.6

—

Emotional disorders starting during childhood or adolescence

0.00

0.0

3.0

—

KRA_PSY_EATING, excluding more controls

0.00

0.0

2.8

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.0

1.2

—

Other (not insulin) diabetes medications

0.87

0.00

1.6

2.3

—

Specific development disorders of scholastic skills

0.00

0.0

3.2

—

Macular pucker

0.00

0.0

1.6

—

Acute appendicitis, with complications

0.00

0.0

1.8

—

Alzheimer’s disease (Late onset)

0.00

0.0

2.3

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.0

1.5

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.01

0.00

2.4

—

L02BA Anti-estrogens

0.00

0.0

1.5

—

Use of other anti-dementia drugs

0.00

0.0

2.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

0.00

0.0

1.7

—

Use of memantine

0.00

0.0

2.3

—

Foreign body on external eye

0.00

0.0

2.8

—

Tinnitus

0.00

0.0

1.6

—

LSIL lesion of the cervix uteri

0.00

0.0

2.8

—

Other skin changes

0.00

0.0

2.2

—

Other and unspecified mood [affective] disorders

0.00

-0.00

0.0

3.2

—

Other congenital malformations

0.00

-0.00

0.0

3.0

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

-0.00

0.0

1.3

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

3.2

—

Endometriosis ASRM stages 3,4

0.00

-0.00

0.0

1.9

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

3.2

—

Other diseases of upper respiratory tract

0.99

-0.00

2.3

—

Seronegative rheumatoid arthritis

0.00

-0.00

0.0

1.2

—

Recurrent aphthous stomatitis , including avohilmo

0.00

-0.00

0.0

2.8

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.00

-0.00

0.0

2.2

—

Other disorders of ear

0.94

-0.00

1.8

2.3

—

Lichen planus, including avohilmo

0.00

-0.00

0.0

1.3

—

Congenital malformations of the circulatory system

0.00

-0.00

0.0

2.8

—

Deep bite

0.00

-0.00

0.0

2.8

—

Abnormalities of forces of labour

0.00

-0.00

0.0

2.6

—

Benign neoplasm: Rectum

0.00

-0.00

0.0

1.2

—

Soft tissue disorders

0.86

-0.00

2.7

2.1

—

Scoliosis

0.00

-0.00

0.0

3.2

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

-0.00

0.0

2.8

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

2.8

—

Autoimmune diseases excluding thyroid diseases

0.98

-0.00

2.6

2.3

—

Congenital malformations of genital organs

0.00

-0.00

0.0

3.2

—

Gastric ulcer

0.00

-0.00

0.0

1.6

—

Voice disturbances

0.00

-0.00

0.0

1.6

—

Autoimmune diseases

0.91

-0.00

1.9

2.3

—

Cardiomyopathies, Primary/intrinsic

0.00

-0.00

0.0

1.4

—

Caries of dentine

0.00

-0.00

0.0

2.6

—

Disorders of psychological development

0.00

-0.00

0.0

2.9

—

Benign neoplasm: Sigmoid colon

0.00

-0.00

0.0

1.2

—

Fracture of femur

0.00

-0.00

0.0

2.1

—

Lateral epicondylitis

0.00

-0.00

0.0

1.6

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.92

-0.00

1.8

2.3

—

Salpingitis and oophoritis

0.00

-0.00

0.0

1.6

—

Hypothyroidism, other/unspecified

0.96

-0.00

1.8

2.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.01

-0.00

1.8

2.2

—

Selective serotonin reuptake inhibitors

0.98

-0.00

2.7

2.4

—

Specific development disorders of speech and language

0.00

-0.00

0.0

3.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

-0.00

0.0

2.6

—

Other respiratory disorders and diseases

0.00

-0.00

0.0

1.6

—

Status post-ami

0.00

-0.00

0.0

2.2

—

Viral warts

0.00

-0.00

0.0

3.2

—

Otitis media, unspecified

0.00

-0.00

0.0

2.4

—

Thoracic aortic aneurysm

0.00

-0.00

0.0

1.7

—

Acute laryngitis and tracheitis

0.00

-0.00

0.0

3.6

—

Alzheimer’s disease, strict definition

0.00

-0.00

0.0

2.3

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

-0.00

0.0

1.3

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.6

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

-0.00

0.0

2.2

—

Diabetes medication

0.91

-0.00

2.0

2.4

—

Certain conditions originating in the perinatal period

0.00

-0.00

0.0

3.1

—

0.00

-0.00

0.0

2.1

—

Use of pramipexole

0.00

-0.00

0.0

1.3

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

2.2

—

Superficial injury of shoulder and upper arm

0.00

-0.00

0.0

2.8

—

Endometriosis of ovary

0.00

-0.00

0.0

2.9

—

Other disorders starting during childhood or adolescence

0.00

-0.00

0.0

2.8

—

Obstructed labour due to maternal pelvic abnormality

0.00

-0.00

0.0

2.6

—

Other superficial mycoses

0.00

-0.00

0.0

3.2

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

2.8

—

Crossbite

0.00

-0.00

0.0

2.8

—

Seropositive rheumatoid arthritis

0.00

-0.00

0.0

1.7

—

Gastroduodenal ulcer

0.00

-0.00

0.0

1.6

—

Special screening examination for other diseases and disorders

0.00

-0.00

0.0

2.7

—

Schizophrenia

0.00

-0.00

0.0

2.2

—

Impacted maxillary molar

0.00

-0.00

0.0

3.0

—

Wet age-related macular degeneration

0.00

-0.00

0.0

2.1

—

Budesonide

0.00

-0.00

0.0

2.8

—

Congenital malformations of heart and great arteries

0.00

-0.00

0.0

3.2

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

1.8

—

Anorexia (incl.atypical)

0.00

-0.00

0.0

3.2

—

Inguinal hernia, bilateral

0.00

-0.00

0.0

1.6

—

Presence of other devices

0.00

-0.00

0.0

1.6

—

Hypothyroidism, drug reimbursement

0.00

-0.00

0.0

1.7

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.94

-0.00

1.8

2.5

—

Persons encountering health services for specific procedures and health care

0.93

-0.00

2.1

2.3

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

-0.00

0.0

3.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

0.98

-0.00

2.6

2.3

—

Persistent mood disorders

0.00

-0.00

0.0

2.6

—

0.00

-0.00

0.0

2.8

—

Finngen Rheumatological endpoints

0.95

-0.00

2.2

2.3

—

Other and unspecified nonorganic psychotic disorders

0.00

-0.00

0.0

3.0

—

Other disorders of patella

0.00

-0.00

0.0

1.8

—

Psoriasis vulgaris

0.00

-0.00

0.0

2.0

—

Cardiac arrest

0.00

-0.00

0.0

2.2

—

Abnormal weight loss

0.00

-0.00

0.0

2.8

—

Unspecified privation

0.00

-0.00

0.0

2.0

—

Coronary artery bypass grafting

0.00

-0.00

0.0

2.4

—

Other problems related to primary support group, including family circumstances

0.00

-0.00

0.0

2.6

—

Contact with other sharp object(s)

0.00

-0.00

0.0

3.2

—

Weight loss

0.00

-0.00

0.0

2.8

—

Other/unspecified seropositive rheumatoid arthritis

0.00

-0.00

0.0

1.6

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

-0.00

0.0

1.3

—

Other menopausal disorders

0.00

-0.00

0.0

2.2

—

Other condition

0.00

-0.00

0.0

3.2

—

Bitten or struck by other mammals

0.00

-0.00

0.0

2.8

—

Inguinal or femoral hernia, bilateral

0.00

-0.00

0.0

1.6

—

Diseases of the eye and adnexa

0.96

-0.00

2.2

2.5

—

Eating disorders

0.00

-0.00

0.0

2.9

—

Embedded teeth, including avohilmo

0.00

-0.00

0.0

3.0

—

Insulin, fast-acting (human)

0.00

-0.00

0.0

2.7

—

Acne vulgaris

0.00

-0.00

0.0

3.0

—

Alcohol abuse, main dg

0.00

-0.00

0.0

2.8

—

Other diseases of the respiratory system

0.00

-0.00

0.0

1.6

—

Continuous positive airway pressure

0.00

-0.00

0.0

2.7

—

Aortic aneurysm

0.00

-0.00

0.0

2.1

—

Speech and linguistic disorders

0.00

-0.00

0.0

2.9

—

Acne

0.00

-0.00

0.0

3.0

—

Cervicalgia

0.00

-0.00

0.0

3.0

—

Myopia

0.00

-0.00

0.0

3.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

-0.00

0.0

2.6

—

Injuries to unspecified part of trunk, limb or body region

0.00

-0.00

0.0

2.8

—

Valvular operations

0.00

-0.00

0.0

1.4

—

Other (seronegative) rheumatoid arthritis, wide

0.00

-0.00

0.0

1.2

—

Eating disorder

0.00

-0.00

0.0

3.0

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

2.2

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Plasmodium malariae Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS